This study aims to evaluate the effects of a new medication on blood pressure in adults. Participants will be randomly assigned to receive either the medication or a placebo. The study will last for 12 weeks, during which participants will have regular check-ups to monitor their blood pressure and overall health. The goal is to determine if the medication is effective in lowering blood pressure compared to the placebo.
- Who Can Participate: Adults aged 18-65 with a diagnosis of hypertension
- Study Details: Participants will receive either the new medication or a placebo for 12 weeks, with regular health assessments
- Study Timelines and Visits: The study will begin in January 2024 and conclude in March 2024.Participants are required to attend 5 visits over the 12-week study period